NCT00464438

A Study to Evaluate the Safety and Efficacy of Gatifloxacin for the Treatment of Bacterial Conjunctivitis

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 171 (actual)
• Sponsor: Allergan · Industry
• Sex: All
• Age: 31 Days
• Healthy volunteers: Not accepted

Summary

This is a 7 day study to evaluate the safety and efficacy of topical gatifloxacin ophthalmic solution for the treatment of bacterial conjunctivitis in subjects from birth to 31 days of age

Conditions

• Bacterial Conjunctivitis

Interventions

Type	Name	Description
DRUG	gatifloxacin	Day 1-6 = 1 drop of study medication three times a day
DRUG	moxifloxacin 0.5% eye drops	Day 1-6 = 1 drop of study medication three times a day

Timeline

• Start date: 2007-06-01
• Primary completion: 2008-09-01
• Completion: 2008-09-01
• First posted: 2007-04-23
• Last updated: 2011-09-21
• Results posted: 2011-09-21

Locations

2 sites across 2 countries: United States, Canada